The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries

BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Harm Reduct J
Auteurs principaux: Maticic, M., Pirnat, Z., Leicht, A., Zimmermann, R., Windelinck, T., Jauffret-Roustide, M., Duffell, E., Tammi, T., Schatz, E.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678126/
https://ncbi.nlm.nih.gov/pubmed/33213481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-020-00439-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires